Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dala N. Daraghmeh"'
Autor:
Dala N. Daraghmeh, Mahin Moghaddami, Larisa Bobrovskaya, Susanna M. Proudman, Michael D. Wiese
Publikováno v:
Analytical and bioanalytical chemistry. 414(20)
Low-dose methotrexate (MTX) plays a key role in treatment of rheumatoid arthritis. However, not all patients respond satisfactorily, and no therapeutic drug monitoring has been implemented in clinical practice, despite the fact that MTX therapy has n
Autor:
Dala N Daraghmeh, Ashley M Hopkins, Catherine King, Ahmad Y Abuhelwa, Mihir D Wechalekar, Susanna M Proudman, Michael J Sorich, Michael D Wiese
Objectives Sex is well known to influence risk, severity and treatment outcomes of RA, although the underlying causes are uncertain. The aim of this research was to examine whether factors influencing female sex hormones (reproductive status and exog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb124f68452edb0f0f380af414342da9
https://hdl.handle.net/11541.2/30192
https://hdl.handle.net/11541.2/30192
Publikováno v:
Pharmacological Research. 173:105887
Refereed/Peer-reviewed Rheumatoid arthritis (RA) is a common autoimmune inflammatory disease affecting 0.5-1% of adults worldwide. Achieving long term remission or low disease activity is possible through early diagnosis, rapid initiation of disease
Autor:
Diana O. Mezyed, Rahmat Awang, Samah W. Al-Jabi, Mayas N. Sawafta, Razan L. Khdeir, Nora A. Ayaseh, Sa’ed H. Zyoud, Waleed M. Sweileh, Dala N. Daraghmeh, Ghada H. Tabeeb
Publikováno v:
BMC Complementary and Alternative Medicine
Background Complementary and alternative medicine (CAM), and herbal therapies, are accepted worldwide, and have been important from medical, sociological and economic perspectives, among haemodialysis (HD) patients. The primary aim of this study was
Autor:
Nora A. Ayaseh, Sa’ed H. Zyoud, Rahmat Awang, Waleed M. Sweileh, Ghada H. Tabeeb, Samah W. Al-Jabi, Razan L. Khdeir, Diana O. Mezyed, Mayas N. Sawafta, Dala N. Daraghmeh
Publikováno v:
The Lancet. 391:S32
Background Haemodialysis is a life-saving but burdensome therapy for patients with end-stage renal disease, which can substantially impair health-related quality of life (HRQOL) and outcomes. The aim of this study was to determine the patterns of HRQ
Autor:
Diana O. Mezyed, Rahmat Awang, Ghada H. Tabeeb, Razan L. Khdeir, Waleed M. Sweileh, Samah W. Al-Jabi, Nora A. Ayaseh, Sa’ed H. Zyoud, Mayas N. Sawafta, Dala N. Daraghmeh
Publikováno v:
BMC Nephrology
Background Haemodialysis (HD) is a life-sustaining treatment for patients with end-stage renal disease (ESRD). HD can bring about significant impairment in health-related quality of life (HRQOL) and outcomes. Therefore, we sought to describe the patt